Literature DB >> 378359

Differences in age and sex distributions among patients with non-Hodgkin's lymphoma.

L Elias.   

Abstract

The records of a group of 337 adult patients with non-Hodgkin's lymphoma seen at the Stanford University Medical Center, Division of Oncology were examined for relationships between stage and histopathological classification and simple demographic characteristics. Patients with Stages I and II of disease and diffuse varieties of lymphoma were found to be younger than patients in other categories. An excess of male patients was noted particularly in younger patients with diffuse lymphoma and Stages I and II of disease. Male patients with Stages I and II disease were noted to be bimodally distributed with respect to age, with peak number of patients in the fourth and sixth decades. This was particularly apparent among patients with diffuse histiocytic lymphoma. The implications of these findings are discussed.

Entities:  

Mesh:

Year:  1979        PMID: 378359     DOI: 10.1002/1097-0142(197906)43:6<2540::aid-cncr2820430655>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy.

Authors:  U Schmalhorst; H Bartels; I Boll; A Burger-Schüler; H Common; H H Fülle; M Graubner; R Heinz; D Huhn; H Leopold; P Meusers; L Nowicki; R Nürnberger; J Oertel; U Rühl; G Sieber; M Schmidt; A Schoengen; A Strassner; E W Schwarze; G Brittinger
Journal:  Blut       Date:  1981-09

2.  CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosis.

Authors:  R Heinz; E Neumann; P Aiginger; J Pont; J Schüller; G Walcher; H Hanak; T Radaszkiewicz; E Sinn; M Wirth
Journal:  Blut       Date:  1985-05

3.  A 15-year series of gastrointestinal non-Hodgkin's lymphomas: a population-based study.

Authors:  M Ducreux; M C Boutron; F Piard; P M Carli; J Faivre
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  Histological, epidemiological and clinical aspects of centroblastic-centrocytic lymphomas subdivided according to the "working formulation".

Authors:  W M Molenaar; H Bartels; J Koudstaal
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.